During the last three months, 4 analysts shared their evaluations of MaxLinear (NASDAQ:MXL), revealing diverse outlooks from bullish to bearish.
The table below provides a snapshot of their recent ratings, showcasing how sentiments have evolved over the past 30 days and comparing them to the preceding months.
Bullish
Somewhat Bullish
Indifferent
Somewhat Bearish
Bearish
Total Ratings
3
1
0
0
0
Last 30D
1
0
0
0
0
1M Ago
1
1
0
0
0
2M Ago
0
0
0
0
0
3M Ago
1
0
0
0
0
Analysts have set 12-month price targets for MaxLinear, revealing an average target of $27.0, a high estimate of $30.00, and a low estimate of $25.00. This upward trend is evident, with the current average reflecting a 5.88% increase from the previous average price target of $25.50.
Diving into Analyst Ratings: An In-Depth Exploration
In examining recent analyst actions, we gain insights into how financial experts perceive MaxLinear. The following summary outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
Analyst
Analyst Firm
Action Taken
Rating
Current Price Target
Prior Price Target
Quinn Bolton
Needham
Maintains
Buy
$25.00
-
David Williams
Benchmark
Raises
Buy
$28.00
$23.00
Tim Savageaux
Northland Capital Markets
Announces
Outperform
$30.00
-
Quinn Bolton
Needham
Lowers
Buy
$25.00
$28.00
Key Insights:
Action Taken: Analysts respond to changes in market conditions and company performance, frequently updating their recommendations. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to MaxLinear. This information offers ...Full story available on Benzinga.com
Benzinga